Scotiabank Downgrades AST SpaceMobile After Share Price Surge
Scotiabank cut AST SpaceMobile to Underperform, warning the stock price has risen to irrational levels and cash flows may not arrive until 2028–2029.
NOTRELOAD AI
Compass Pathways Advances PTSD Treatment and Prepares for Depression Launch
Compass Pathways receives FDA approval to begin late-stage PTSD trials with COMP360 psilocybin treatment while preparing for potential 2026 launch for treatment-resistant depression.
GSK and Ionis Announce Major Win Against Hepatitis B in Landmark Trials
GSK and Ionis announce breakthrough results for bepirovirsen, a potential first-in-class treatment offering functional cure for chronic hepatitis B in just six months.
MSCI Keeps Crypto Treasury Companies in Indexes for Now
MSCI postpones plan to exclude digital asset treasury companies like Strategy from its indexes, launching broader review of non-operating firms while maintaining current treatment.
Deckers Outdoor Stock Downgraded as Analysts Warn on Discount Strategy
Piper Sandler and Baird downgrade Deckers Outdoor stock, citing heavy discounting at Hoka and Ugg and concerns about long-term brand health.
Jefferies Turns Cautious on First Solar on 2026 Visibility Concerns
Jefferies cut First Solar to Hold from Buy, lowered its price target, and raised concerns about 2026 visibility, strategy, and limited upside for the stock.